Hannah Dellabella is a freelance writer for Haymarket Media. She holds an MFA in creative writing from Purdue University and a BA in creative writing and professional writing from Carnegie Mellon University. Previously, she was the associate editor for Clinical Advisor at Haymarket Media and an assistant editor for the Haymarket Medical Network. In addition to being a medical writer, Hannah is a poet whose work has appeared in various literary journals.
Researchers identified clinical predictors and genes to improve the clinical model, which they believe shows elevation of synovial lymphoid-associated genes was linked to autoantibody positivity or elevation of osteoclast-targeting genes and predicted joint damage progression by the end of the first year.
Researchers found data indicating that cardiac magnetic resonance imaging showed that patients who were believed to be at risk for rheumatoid arthritis, based on anti-cyclic citrullinated peptide levels in their blood, were found to have aortic stiffness.
Patients with rheumatoid arthritis who were examined for hallux valgus and flatfoot were found to have functional disability in walking, so the researchers recommend early diagnosis for hallux valgus and flatfoot.
Researchers reviewed current recommendations for the treatment of rheumatoid arthritis and found a contraindication for the use of tumor necrosis factor inhibitors in patients at risk for lymphoma, and that treatment should be stopped and re-evaluated in patients who are newly diagnosed with cancer.
In the assessment of joint inflammation and structural damage in rheumatoid arthritis (RA), researchers determined that data did not support applying the RA MRI scoring system to the metatarsophalangeal joints as a valid outcome measure.
Participants with early rheumatoid arthritis in the Swedish Pharmacotherapy clinical trial who were treated with methotrexate therapy for 3 months were found to have baseline level biomarkers of low C-reactive protein and leptin with high tumor necrosis factor receptor 1 and vascular cell adhesion molecule 1 that were associated with low disease activity.